Skip to Content

Pfizer PBC 125 (Ibrance 125 mg)

Generic Name: palbociclib

Pill with imprint Pfizer PBC 125 is Purple, Elliptical / Oval and has been identified as Ibrance 125 mg. It is supplied by Pfizer Inc..

Ibrance is used in the treatment of breast cancer, metastatic; liposarcoma; breast cancer; breast cancer, male and belongs to the drug class CDK 4/6 inhibitors. Ibrance 125 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for Pfizer PBC 125

Ibrance

Generic Name
palbociclib
Imprint
Pfizer PBC 125
Strength
125 mg
Color
Purple
Shape
Elliptical / Oval
Availability
Prescription only
Drug Class
CDK 4/6 inhibitors
CSA Schedule
Not a controlled drug
Labeler / Supplier
Pfizer Inc.
National Drug Code (NDC)
00069-0688

Get help with Imprint Code FAQs.

Related Images for "Pfizer PBC 125"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.